Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018805
Filing Date
2023-05-08
Accepted
2023-05-08 16:10:22
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-20230331.htm   iXBRL 10-Q 3091536
2 EX-10.1 rvmd-ex10_1.htm EX-10 59976
3 EX-10.2 rvmd-ex10_2.htm EX-10 313047
4 EX-31.1 rvmd-ex31_1.htm EX-31 20746
5 EX-31.2 rvmd-ex31_2.htm EX-31 20697
6 EX-32.1 rvmd-ex32_1.htm EX-32 10622
7 EX-32.2 rvmd-ex32_2.htm EX-32 10612
8 GRAPHIC img244834026_0.jpg GRAPHIC 1476
9 GRAPHIC img244834026_1.jpg GRAPHIC 122814
  Complete submission text file 0000950170-23-018805.txt   11222734

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvmd-20230331_def.xml EX-101.DEF 177196
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvmd-20230331_cal.xml EX-101.CAL 54714
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvmd-20230331.xsd EX-101.SCH 58409
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvmd-20230331_pre.xml EX-101.PRE 325028
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvmd-20230331_lab.xml EX-101.LAB 458935
67 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20230331_htm.xml XML 2264586
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 23897823
SIC: 2836 Biological Products, (No Diagnostic Substances)